Arix Bioscience plc competitors

Jeff Albers is the chief executive officer of [Blueprint Medicines](https://www.crunchbase.com/organization/blueprint-medicines), a company engaged in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets. He was previously the president of Algeta. Prior to Algeta, he served at Genzyme, where he spent seven years in senior commercial and corporate development positions. Before joining Genzyme, he spent five years as an Attorney at the law firm Mintz Levin Cohn Ferris Glovsky & Popeo. He also has prior experience as a sales representative for Pfizer. Albers holds a bachelor’s degree in marketing from Indiana University and an MBA from Georgetown University.

Emil Kakkis (born 1960) is an American medical geneticist known for his work to develop treatments for ultra rare disorders. He is the President and Founder of the Kakkis Everylife Foundation for Rare Disease and Chief Executive Officer and President at Ultragenyx Pharmaceutical Inc.

Anirvan Ghosh is an American neuroscientist and Biotech executive. His research has contributed to our understanding of the molecular mechanisms that regulate development and function of the mammalian brain. A major focus of his research has been to identify mechanisms that regulate neuronal connectivity and the effects of neuronal activity on brain development. He served as the Global Head of Neuroscience Discovery at F. Hoffmann-La Roche from 2011 to 2016 and as founding CSO of E-Scape Bio from 2016-2017. He was the Head of Research and Early Development at Biogen from 2017-2020 and is currently the CEO of Unity Biotechnology.

Technology and Payments EntrepreneurSpecialties: Electronic payments, prepaid, merchant processing both on and offline, global remittance processing, financial services technologies, rent and lease related payments processing, payments compliance, money transfer, mobile money transfer.

Experienced executive with a record of success in both Pharma and Biotech. A recognized scientific expert in medicinal chemistry who is also well versed in disease biology and the enabling technologies needed for effective and efficient drug discovery. Demonstrated ability to work internationally and across cultures.